FMN improves lipid profile in diabetes. FMN significantly reduced LDL (A), cholesterol (B), and triglyceride (C) levels in diabetic mice. Mice were fed with HFD for 9 weeks followed by two low doses of STZ injection (40 mg/kg) after diabetes was confirmed, mice were treated with 20 mg/kg FMN or 200 mg/kg metformin for 10 days, mice were then sacrificed, and serum collected for ELISA analysis. One-way ANOVA followed by Tukey post hoc, ***<0.001. VC; vehicle control.

 
 
  Part of: Qnais E, Alqudah A, Wedyan M, Gammoh O, Alkhateeb H, Al-Noaimi M (2023) Formononetin suppresses hyperglycaemia through activation of GLUT4-AMPK pathway. Pharmacia 70(3): 527-536. https://doi.org/10.3897/pharmacia.70.e104160